Millennium Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,110
| Closed | -$37K | – | 4454 |
|
|
2025
Q1 | $37K | Buy |
+51,110
| New | +$37K | ﹤0.01% | 3846 |
|
|
2024
Q4 | – | Sell |
-20,655
| Closed | -$16.3K | – | 4538 |
|
|
2024
Q3 | $16.3K | Buy |
20,655
+8,450
| +69% | +$6.66K | ﹤0.01% | 4002 |
|
|
2024
Q2 | $11.6K | Sell |
12,205
-57,993
| -83% | -$54.9K | ﹤0.01% | 3867 |
|
|
2024
Q1 | $75.8K | Buy |
70,198
+39,847
| +131% | +$43K | ﹤0.01% | 3859 |
|
|
2023
Q4 | $16.7K | Buy |
+30,351
| New | +$16.7K | ﹤0.01% | 3921 |
|
|
2023
Q3 | – | Sell |
-12,894
| Closed | -$33.8K | – | 4642 |
|
|
2023
Q2 | $33.8K | Sell |
12,894
-3,852
| -23% | -$10.1K | ﹤0.01% | 4010 |
|
|
2023
Q1 | $53K | Sell |
16,746
-10,146
| -38% | -$32.1K | ﹤0.01% | 4194 |
|
|
2022
Q4 | $72K | Sell |
26,892
-739
| -3% | -$1.98K | ﹤0.01% | 4382 |
|
|
2022
Q3 | $80K | Sell |
27,631
-22,325
| -45% | -$64.6K | ﹤0.01% | 4750 |
|
|
2022
Q2 | $146K | Buy |
+49,956
| New | +$146K | ﹤0.01% | 4580 |
|